| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.19B | +30.7% |
| Cost of Revenue | $263.0M | +26.8% |
| Gross Profit | $1.92B | +31.2% |
| R&D Expense | $934.9M | +202.0% |
| SG&A Expense | $512.1M | +189.0% |
| Operating Income | -$1.04B | -1572.0% |
| Pre-tax Income | -$1.01B | -4338.7% |
| Income Tax | $831K | -68.2% |
| Net Income | -$1.01B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $466.3M | +38.1% |
| Accounts Receivable | $257.9M | +19.3% |
| Current Assets | $1.76B | +36.4% |
| Total Assets | $1.96B | +34.5% |
| Current Liabilities | $387.9M | +3.5% |
| Total Liabilities | $562.9M | +12.2% |
| Stockholders' Equity | $1.40B | +172.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $52.8M | -17.7% |
| Investing Cash Flow | -$289.7M | -734.5% |
| Financing Cash Flow | $367.7M | — |
| -3884.9% |
| EPS (Basic) | -$4.27 | -994.9% |
| EPS (Diluted) | -$4.27 | -994.9% |